Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...
A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.
Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...
New blood test could show if prostate cancer treatment is failing - The discovery could lead to personalised treatments for ...
A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...
Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...
Prostate cancer screening could save thousands of lives a year and should be made an option for the vast majority of men, a ...
Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...
20/20 BioLabs, Inc. a conclu un accord de licence mondial exclusif avec l'Université de Caroline du Sud pour la ...